Quality of life and pharmacoeconomics: an introduction
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Philadelphia [u.a.]
Lippincott-Raven
1998
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIV, 274 S. graph. Darst. |
| ISBN: | 0397518455 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV011947733 | ||
| 003 | DE-604 | ||
| 005 | 20151027 | ||
| 007 | t | ||
| 008 | 980518s1998 d||| |||| 00||| eng d | ||
| 020 | |a 0397518455 |9 0-397-51845-5 | ||
| 035 | |a (OCoLC)37580695 | ||
| 035 | |a (DE-599)BVBBV011947733 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-19 | ||
| 050 | 0 | |a RS100 | |
| 082 | 0 | |a 338.4/36151 |2 21 | |
| 100 | 1 | |a Cramer, Joyce A. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Quality of life and pharmacoeconomics |b an introduction |c Joyce A. Cramer ; Bert Spilker |
| 264 | 1 | |a Philadelphia [u.a.] |b Lippincott-Raven |c 1998 | |
| 300 | |a XIV, 274 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Economische aspecten |2 gtt | |
| 650 | 2 | |a Essais cliniques comme sujet | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Kwaliteit van het bestaan |2 gtt | |
| 650 | 4 | |a Médicaments - Coût-efficacité | |
| 650 | 4 | |a Qualité de la vie | |
| 650 | 2 | |a Qualité vie | |
| 650 | 2 | |a Traitement médicamenteux - Économie | |
| 650 | 4 | |a Wirtschaft | |
| 650 | 4 | |a Drugs |x Cost effectiveness | |
| 650 | 4 | |a Economics, Pharmaceutical | |
| 650 | 4 | |a Outcome Assessment (Health Care) | |
| 650 | 4 | |a Quality of Life | |
| 650 | 4 | |a Quality of life | |
| 650 | 0 | 7 | |a Lebensqualität |0 (DE-588)4034922-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | 1 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 1 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 2 | 1 | |a Lebensqualität |0 (DE-588)4034922-6 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Spilker, Bert |e Verfasser |0 (DE-588)17151419X |4 aut | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008077482&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008077482 | ||
Datensatz im Suchindex
| _version_ | 1804126535132643328 |
|---|---|
| adam_text | List of Figures and Tables
FIG. 1.1. Three levels of HRQOL 4
FIG. 1.2. Model of clinical effects on HRQOL 8
FIG. 1.3. Relationship among HRQOL factors 13
FIG. 1.4. Model of taxonomy 16
FIG. 1.5. Dimensions of individual patient outcome 19
FIG. 1.6. Hierarchy of patient outcome 20
FIG. 1.7. Clinical assessment of impairment, disability, and handicap .. 38
FIG. 2.1. Models of disease severity 50
FIG. 3.1. Dartmouth COOP chart: social assessment 67
FIG. 3.2. SF 36 measurement model 85
FIG. 4.1. Graphical displays of HRQOL data 106
FIG. 4.2. Functional assessment model 125
FIG. 6.1. Development of utility measures 194
FIG. 6.2. Standard gamble 199
FIG. 6.3. Time trade off 200
FIG. 7.1. Cost effectiveness analysis 239
FIG. 7.2. Quality adjusted life year 240
FIG. 7.3. Health care expenditures 245
FIG. 7.4. Administrative databases 248
FIG. 7.5. Sample decision tree 257
ix
x LIST OF FIGURES AND TABLES
TABLE 1.1. Qualities of a good HRQOL measure 23
TABLE 1.2. Taxonomy of measures of HRQOL 26
TABLE 1.3. Modes of administration of HRQOL measures 30
TABLE 1.4. Incorporating HRQOL assessment into clinical practice . 36
TABLE 3.1. Sample SIP items 87
TABLE 3.2. SIP categories 87
TABLE 3.3. WHOQOL domains and facets 89
TABLE 4.1. Generic scale content 112
TABLE 4.2. Correlation among scales 115
TABLE 4.3. Instrument development 124
TABLE 4.4. Cross cultural equivalence 143
TABLE 6.1. Components of instruments 207
TABLE 6.2. Resource allocation 215
TABLE 6.3. Public policy context 216
TABLE 7.1. Direct costs 228
TABLE 7.2. Indirect costs 228
TABLE 7.3. Cost comparison 229
TABLE 7.4. Selected efficacy categories 230
TABLE 7.5. Examples of pharmacoeconomic variables 230
TABLE 7.6. Definitions of CEA, CUA, CBA 238
TABLE 7.7. CUA example 243
TABLE 7.8. Cost considerations 243
TABLE 7.9. Example of HRQOL and ADR 244
TABLE 7.10. Administrative databases 249
Contents
Introduction vi
Acknowledgments vii
List of Figures and Tables ix
List of Selected Abbreviations xi
About the Authors xiii
1. Introduction 1
2. Social and Psychological Assessment 49
3. Selected Instruments 65
4. Reported Methodology 95
5. Special Populations and Specific Diseases 151
6. Utilities and Outcomes 193
7. Pharmacoeconomics 221
Subject Index 265
v
|
| any_adam_object | 1 |
| author | Cramer, Joyce A. Spilker, Bert |
| author_GND | (DE-588)17151419X |
| author_facet | Cramer, Joyce A. Spilker, Bert |
| author_role | aut aut |
| author_sort | Cramer, Joyce A. |
| author_variant | j a c ja jac b s bs |
| building | Verbundindex |
| bvnumber | BV011947733 |
| callnumber-first | R - Medicine |
| callnumber-label | RS100 |
| callnumber-raw | RS100 |
| callnumber-search | RS100 |
| callnumber-sort | RS 3100 |
| callnumber-subject | RS - Pharmacy |
| ctrlnum | (OCoLC)37580695 (DE-599)BVBBV011947733 |
| dewey-full | 338.4/36151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/36151 |
| dewey-search | 338.4/36151 |
| dewey-sort | 3338.4 536151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02434nam a2200637 c 4500</leader><controlfield tag="001">BV011947733</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20151027 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980518s1998 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0397518455</subfield><subfield code="9">0-397-51845-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)37580695</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011947733</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS100</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/36151</subfield><subfield code="2">21</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cramer, Joyce A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Quality of life and pharmacoeconomics</subfield><subfield code="b">an introduction</subfield><subfield code="c">Joyce A. Cramer ; Bert Spilker</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Lippincott-Raven</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 274 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Economische aspecten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Essais cliniques comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kwaliteit van het bestaan</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Coût-efficacité</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Qualité de la vie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Qualité vie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Traitement médicamenteux - Économie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Outcome Assessment (Health Care)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality of Life</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality of life</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lebensqualität</subfield><subfield code="0">(DE-588)4034922-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Lebensqualität</subfield><subfield code="0">(DE-588)4034922-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Spilker, Bert</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)17151419X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008077482&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008077482</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV011947733 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:19:00Z |
| institution | BVB |
| isbn | 0397518455 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008077482 |
| oclc_num | 37580695 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM |
| owner_facet | DE-12 DE-19 DE-BY-UBM |
| physical | XIV, 274 S. graph. Darst. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Lippincott-Raven |
| record_format | marc |
| spelling | Cramer, Joyce A. Verfasser aut Quality of life and pharmacoeconomics an introduction Joyce A. Cramer ; Bert Spilker Philadelphia [u.a.] Lippincott-Raven 1998 XIV, 274 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Economische aspecten gtt Essais cliniques comme sujet Geneesmiddelen gtt Kwaliteit van het bestaan gtt Médicaments - Coût-efficacité Qualité de la vie Qualité vie Traitement médicamenteux - Économie Wirtschaft Drugs Cost effectiveness Economics, Pharmaceutical Outcome Assessment (Health Care) Quality of Life Quality of life Lebensqualität (DE-588)4034922-6 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Gesundheitsökonomie (DE-588)4130935-2 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Pharmakotherapie (DE-588)4076066-2 s Gesundheitsökonomie (DE-588)4130935-2 s DE-604 Kosten-Nutzen-Analyse (DE-588)4032589-1 s Lebensqualität (DE-588)4034922-6 s Spilker, Bert Verfasser (DE-588)17151419X aut HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008077482&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Cramer, Joyce A. Spilker, Bert Quality of life and pharmacoeconomics an introduction Economische aspecten gtt Essais cliniques comme sujet Geneesmiddelen gtt Kwaliteit van het bestaan gtt Médicaments - Coût-efficacité Qualité de la vie Qualité vie Traitement médicamenteux - Économie Wirtschaft Drugs Cost effectiveness Economics, Pharmaceutical Outcome Assessment (Health Care) Quality of Life Quality of life Lebensqualität (DE-588)4034922-6 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| subject_GND | (DE-588)4034922-6 (DE-588)4032589-1 (DE-588)4130935-2 (DE-588)4076066-2 (DE-588)4143413-4 |
| title | Quality of life and pharmacoeconomics an introduction |
| title_auth | Quality of life and pharmacoeconomics an introduction |
| title_exact_search | Quality of life and pharmacoeconomics an introduction |
| title_full | Quality of life and pharmacoeconomics an introduction Joyce A. Cramer ; Bert Spilker |
| title_fullStr | Quality of life and pharmacoeconomics an introduction Joyce A. Cramer ; Bert Spilker |
| title_full_unstemmed | Quality of life and pharmacoeconomics an introduction Joyce A. Cramer ; Bert Spilker |
| title_short | Quality of life and pharmacoeconomics |
| title_sort | quality of life and pharmacoeconomics an introduction |
| title_sub | an introduction |
| topic | Economische aspecten gtt Essais cliniques comme sujet Geneesmiddelen gtt Kwaliteit van het bestaan gtt Médicaments - Coût-efficacité Qualité de la vie Qualité vie Traitement médicamenteux - Économie Wirtschaft Drugs Cost effectiveness Economics, Pharmaceutical Outcome Assessment (Health Care) Quality of Life Quality of life Lebensqualität (DE-588)4034922-6 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| topic_facet | Economische aspecten Essais cliniques comme sujet Geneesmiddelen Kwaliteit van het bestaan Médicaments - Coût-efficacité Qualité de la vie Qualité vie Traitement médicamenteux - Économie Wirtschaft Drugs Cost effectiveness Economics, Pharmaceutical Outcome Assessment (Health Care) Quality of Life Quality of life Lebensqualität Kosten-Nutzen-Analyse Gesundheitsökonomie Pharmakotherapie Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008077482&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT cramerjoycea qualityoflifeandpharmacoeconomicsanintroduction AT spilkerbert qualityoflifeandpharmacoeconomicsanintroduction |